-
Taxonomy & unit
-
ratio: %
-
Description
-
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
-
Summary
-
Inhibikase Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2023 to Q3 2024.
- Inhibikase Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 232 %, a 70% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)